Welcome to our dedicated page for Biomx news (Ticker: PHGE), a resource for investors and traders seeking the latest updates and insights on Biomx stock.
BiomX Inc. (PHGE) news is centered on the company’s transition from a legacy phage therapy profile toward defense, security, critical infrastructure, and first-response technologies. Recent company announcements focus heavily on Zorronet, an AI defense technology subsidiary that develops command-and-control, computer vision, and autonomous surveillance systems.
PHGE news can include acquisition updates, material agreements, customer deployments, and operating details tied to Zorronet and DFSL. Zorronet-related coverage has included AI command-and-control software, secure on-premise and hybrid C5ISR deployments, mobile field-operator tools, and the use of cameras, sensors, drones, and IoT devices in integrated security environments.
Infrastructure and government-related items are also important for BiomX coverage. Company disclosures have discussed Zorronet’s work with Israel Railways, contracts with the Israel Defense Forces, and engagements involving government customers, Tier-1 OEMs such as Elbit Systems, and international clients. DFSL adds another news angle through LADAR-based detection systems for perimeter security, critical infrastructure, and counter-UAS markets.
BiomX news may also include SEC filing events, shareholder votes, governance changes, capital-structure disclosures, and operating results. Because the company has disclosed substantial doubt about its ability to continue as a going concern, financing and liquidity-related disclosures are also material to PHGE coverage. For investors tracking PHGE, the main news themes are defense technology acquisitions, operational deployments, critical infrastructure agreements, and the company’s remaining phage therapy background.
BiomX (NYSE American: PHGE) reported that its subsidiary Zorronet received an approximately $300,000 purchase order to plan, integrate and deploy a unified operational environment at a defense technology test and evaluation site.
Zorronet will design communications, computing and control infrastructure, integrate multiple systems and deploy a dedicated command-and-control center, managing the project from initial characterization through operational handover. According to BiomX, this site-level deployment is a strategically important reference in complex defense testing environments and may support a repeatable offering for additional facilities in Israel and abroad. The customer’s identity and site details are not disclosed for confidentiality reasons.
BiomX (NYSE American: PHGE) agreed to acquire a 10% stake in Motomea, comprising M.E.A. Testing Systems and Mea Motomova India, for $50,000 in cash plus an undertaking to issue 1,300,000 restricted shares to Motomea’s ultimate majority owner, subject to regulatory and NYSE approval.
The deal includes an exclusive license for BiomX to develop and distribute drone testing solutions based on Motomea’s electric motor validation technologies. BiomX also obtained an option to acquire control of Motomea, at its sole discretion and subject to due diligence, at a purchase price calculated as 2x Motomea’s 2027 net revenue and 4x its 2028 EBITDA, multiplied by 90%, payable in a mix of cash and shares.
Motomea brings over 25 years of experience and patented inertial dynamometer systems that test electric motors for drones, aircraft, vehicles and robotics, expanding BiomX’s capabilities in electric propulsion testing for unmanned aerial systems and supporting its detection, analysis and response strategy.
BiomX (NYSE American: PHGE) amended the promissory note tied to its April 2026 acquisition of Zorronet from Water.IO (TASE: WATR), restructuring the remaining $1.25 million obligation. The amendment is designed to give BiomX more flexibility in timing its payments while supporting Zorronet’s development.
Under the revised terms, BiomX will issue 800,000 restricted common shares to Water.IO as consideration for the extension and in satisfaction of accrued interest, subject to customary conditions and approvals. The final maturity date of the note is extended to November 1, 2026. BiomX will pay an initial principal instalment of $250,000, followed by four equal monthly payments of $250,000. Zorronet develops AI-powered command-and-control software integrating video analytics, drones, sensors and IoT devices, already used by defense forces, rail operators, governments and Tier‑1 defense OEMs.
BiomX (NYSE American: PHGE) announced that subsidiary Zorronet entered a strategic collaboration with Czech firm Samura s.r.o. to expand AI-powered detection, analysis and response solutions across Central and Eastern Europe. The partnership targets agriculture, infrastructure, environmental monitoring, property protection and other monitoring-intensive sectors.
The first joint initiative focuses on AI-driven agricultural and urban pest management, combining Samura’s smart pest control hardware and market reach with Zorronet’s software to analyze sensor and camera data, identify pest activity and trigger autonomous responses. A second collaboration applies Zorronet’s AI monitoring and early-warning capabilities to protect critical transportation infrastructure by detecting animals and unauthorized people before they enter hazardous areas, aiming to reduce wildlife collisions and trespassing incidents. According to BiomX, Samura will lead commercial activities in agreed territories, while its Digital4Pest division will handle technical implementation and support.
BiomX (NYSE American: PHGE) announced that its wholly owned subsidiary Zorronet has completed transitioning core operations to a new advanced data center. The facility is designed to improve response times, cost efficiency, and real-time capacity for complex security events, supporting Zorronet’s infrastructure modernization and business expansion.
BiomX (NYSE American: PHGE) signed a non-binding LOI for a 60% stake in Israeli security integrator Tsoock Defense Technologies for about $10.4 million, subject to due diligence, financing, definitive agreements and approvals.
Tsoock generated NIS 13.1M revenue and NIS 625K net profit in 2025 and could add secure-site integration and infrastructure capabilities to BiomX’s defense and critical-infrastructure security platform.
BiomX (NYSE American: PHGE) reported that subsidiary Zorronet has begun supplying, installing and operating its AI- and ML-powered detection and command-and-control systems on sections of the Israel Railways network under a framework agreement.
The initial phase covers 4 segments, following a pilot with 98% success in keeping large animals off tracks and zero related collisions.
BiomX (NYSE American: PHGE)/b) announced that majority-owned subsidiary will showcase next-generation LADAR-based counter-drone and perimeter security solutions at ISC 2026. The Laser Radar platform uses on-sensor AI for real-time detection, classification, and tracking of UAVs and ground intruders.
According to BiomX, DFSL’s systems target about 99% accuracy, aim to reduce false alarms, and serve counter-UAS defense, border security, wide-area 360° surveillance, and critical infrastructure protection. The technology is backed by patents, government-supported development, and operational deployments in Israel, Africa, and U.S. transportation infrastructure.
BiomX (NYSE American: PHGE) posted an updated presentation outlining its completed strategic transition to defense, security, and first-response markets. The company now focuses on technologies that identify, analyze, and support faster responses to physical threats.
The portfolio includes Zorronet, an AI-powered Autonomous Command Center platform, and DFSL, which develops laser-based threat detection and physical security technologies. BiomX highlights its operating framework, NYSE American compliance plan, and a leadership and advisory team with experience in defense technology, public markets, and large-scale security systems.
BiomX (NYSE American: PHGE) announced NYSE American has accepted its plan to regain compliance with continued listing standards, granting a plan period through September 25, 2027.
The company was previously notified it was non-compliant due to a stockholders’ deficit and multi-year losses. Its shares remain listed during the plan period, subject to ongoing review.